L
Lavanya Kondapalli
Researcher at University of Colorado Boulder
Publications - 30
Citations - 803
Lavanya Kondapalli is an academic researcher from University of Colorado Boulder. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 7, co-authored 22 publications receiving 509 citations. Previous affiliations of Lavanya Kondapalli include University of Colorado Hospital & Western University of Health Sciences.
Papers
More filters
Journal ArticleDOI
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.
Laxmi S. Mehta,Karol E. Watson,Ana Barac,Theresa M. Beckie,Vera Bittner,Salvador Cruz-Flores,Susan Dent,Lavanya Kondapalli,Bonnie Ky,Tochukwu M. Okwuosa,Ileana L. Piña,Annabelle Santos Volgman +11 more
TL;DR: This document will provide a comprehensive overview of the prevalence of these diseases, shared risk factors, the cardiotoxic effects of therapy, and the prevention and treatment of CVD in breast cancer patients.
Journal ArticleDOI
Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations.
Ajjappla Basavaraj Shreya,Renuka S. Managuli,Jyothsna Menon,Lavanya Kondapalli,Aswathi R. Hegde,Kiran Avadhani,Pallavi K. Shetty,Muthukumar Amirthalingam,Guruprasad Kalthur,Srinivas Mutalik +9 more
TL;DR: Dual strategy of permeation enhancement was successful in increasing the transdermal permeation and bioavailability of ASPM through combined strategy of chemical and nano-carrier (transfersomal) based approaches.
Journal ArticleDOI
The promise of molecular targeted therapies: Protein kinase inhibitors in the treatment of cutaneous malignancies
TL;DR: A critical review of the literature is performed, highlighting selective inhibitors of signal transduction molecules involved in nonmelanoma skin cancer, melanoma, dermatofibrosarcoma protuberans, Merkel cell carcinoma, Kaposi's sarcoma, and systemic mastocytosis as discussed by the authors.
Journal ArticleDOI
A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles
TL;DR: It is suggested that the change in the post-hCG E2 level is another parameter that can be used by clinicians to counsel patients regarding their likelihood of success with assisted reproductive technologies prior to oocyte retrieval.
Journal ArticleDOI
Time to recurrence of atrial fibrillation influences outcome following catheter ablation.
Larraitz Gaztañaga,David S. Frankel,Maria Kohari,Lavanya Kondapalli,Erica S. Zado,Francis E. Marchlinski +5 more
TL;DR: In patients with AF after ablation, time to recurrence is a major determinant of outcome and patients with later recurrences are more likely to have sporadic episodes and respond better to AADs and repeat ablation.